Measures
Demographics and self‐reported use of any PrEP or PEP in the prior 6 months were collected by survey at the study baseline. At intervention visits weeks 4, 12 and 24, participant selection of structured choice of prevention option (PrEP, PEP, condoms only and no selection), HIV testing modality (oral self‐test or clinician administered rapid antibody) and preferred location for next visit (clinic vs. out‐of‐facility) was recorded. At week 24, PrEP and PEP use and HIV risk (report of sexual partners with HIV or unknown status and/or self‐identification as being at risk) for each of the prior 6 calendar months were assessed via a structured survey. Enrolment began in April 2021, and the data collection for week 24 concluded in March 2022.